-
Webinar to explore cancer reporting without hype and with the right measure of hope
Experts on an upcoming AHCJ webinar on Wednesday, July 19, will discuss communication about cancer screenings and treatment.
-
Another Alzheimer’s treatment takes a different route than the rest
Editor’s Note: This is part 2 of a two-part package on the pipeline for Alzheimer’s disease drugs. Check out part…
-
Aside from Eli Lilly’s drug, what else is in the Alzheimer’s pipeline?
Eli Lilly recently announced that the FDA had granted a breakthrough therapy designation for donanemab, its investigational antibody therapy for…
-
Alzheimer’s drug approved Monday by FDA raises questions for journalists
Part two of two parts; the first ran Thursday, June 10. There’s still a great deal we don’t yet understand…
-
FDA approves new Alzheimer’s drug, but controversy persists
Part one of two parts; the second runs tomorrow, Friday, June 11. You might think that the first new drug…